According to Orchid Pharma latest financial reports the total debt is $17.72M, an decrease of -28.50% to 2022. At the end of 2022 company had $24.78M total debt. This figure represents the debts and financial obligations that Orchid Pharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $17.72M | -28.50% |
2022 | $24.78M | -51.31% |
2021 | $50.90M | -15.17% |
2020 | $60.00M | -64.62% |
2019 | $169.62M | - |